메뉴 건너뛰기




Volumn 6, Issue 1-2, 2014, Pages 52-58

Cannabinoids, eating behaviour, and energy homeostasis

Author keywords

Endocannabinoids; Energy balance; Feeding; Obesity; Phytocannabinoids

Indexed keywords

DRUG INTERACTIONS; NUTRITION;

EID: 84892459992     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1594     Document Type: Article
Times cited : (27)

References (84)
  • 1
    • 84856431319 scopus 로고    scopus 로고
    • Adolescent exposure to cannabis as a risk factor for psychiatric disorders
    • T. Rubino, E. Zamberletti, D. Parolaro. Adolescent exposure to cannabis as a risk factor for psychiatric disorders. J. Psychopharmacol. 2012, 26, 177.
    • (2012) J. Psychopharmacol. , vol.26 , pp. 177
    • Rubino, T.1    Zamberletti, E.2    Parolaro, D.3
  • 2
    • 33645347973 scopus 로고    scopus 로고
    • Cannabinoids in medicine: A review of their therapeutic potential
    • M. Ben Amar. Cannabinoids in medicine: A review of their therapeutic potential. J. Ethnopharmacol. 2006, 105, 1.
    • (2006) J. Ethnopharmacol. , vol.105 , pp. 1
    • Ben Amar, M.1
  • 5
    • 67449119913 scopus 로고    scopus 로고
    • The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation
    • V. Di Marzo. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol. Res. 2009, 60, 77.
    • (2009) Pharmacol. Res. , vol.60 , pp. 77
    • Di Marzo, V.1
  • 6
    • 75749126604 scopus 로고    scopus 로고
    • Signal transduction of the CB1 cannabinoid receptor
    • G. Turu, L. Hunyady. Signal transduction of the CB1 cannabinoid receptor. J. Mol. Endocrinol. 2010, 44, 75.
    • (2010) J. Mol. Endocrinol. , vol.44 , pp. 75
    • Turu, G.1    Hunyady, L.2
  • 7
    • 33644804271 scopus 로고    scopus 로고
    • The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids
    • R.G. Pertwee. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J. 2005, 7, E625.
    • (2005) AAPS J. , vol.7
    • Pertwee, R.G.1
  • 10
    • 32444440208 scopus 로고    scopus 로고
    • The emerging role of the endocannabinoid system in endocrine regulation and energy balance
    • U. Pagotto, G. Marsicano, D. Cota, B. Lutz, R. Pasquali. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr. Rev. 2006, 27, 73.
    • (2006) Endocr. Rev. , vol.27 , pp. 73
    • Pagotto, U.1    Marsicano, G.2    Cota, D.3    Lutz, B.4    Pasquali, R.5
  • 11
    • 0031736282 scopus 로고    scopus 로고
    • Hyperphagia in pre-fed rats following oral delta9-THC
    • C.M. Williams, P.J. Rogers, T.C. Kirkham. Hyperphagia in pre-fed rats following oral delta9-THC. Physiol. Behav. 1998, 65, 343.
    • (1998) Physiol. Behav. , vol.65 , pp. 343
    • Williams, C.M.1    Rogers, P.J.2    Kirkham, T.C.3
  • 12
    • 0036361973 scopus 로고    scopus 로고
    • Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine
    • C.M. Williams, T.C. Kirkham. Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol. Biochem. Behav. 2002, 71, 333.
    • (2002) Pharmacol. Biochem. Behav. , vol.71 , pp. 333
    • Williams, C.M.1    Kirkham, T.C.2
  • 13
    • 0032936642 scopus 로고    scopus 로고
    • Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors
    • Berl
    • C.M. Williams, T.C. Kirkham. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacol. (Berl.) 1999, 143, 315.
    • (1999) Psychopharmacol. , vol.143 , pp. 315
    • Williams, C.M.1    Kirkham, T.C.2
  • 14
    • 0035984946 scopus 로고    scopus 로고
    • Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol
    • T.C. Kirkham, C.M. Williams, F. Fezza, V. Di Marzo. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol. 2002, 136, 550.
    • (2002) Br. J. Pharmacol. , vol.136 , pp. 550
    • Kirkham, T.C.1    Williams, C.M.2    Fezza, F.3    Di Marzo, V.4
  • 15
    • 77955570050 scopus 로고    scopus 로고
    • Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats
    • Berl
    • J.A. Farrimond, A.J. Hill, B.J. Whalley, C.M. Williams. Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats. Psychopharmacol. (Berl). 2010a, 210, 97.
    • (2010) Psychopharmacol. , vol.210 , pp. 97
    • Farrimond, J.A.1    Hill, A.J.2    Whalley, B.J.3    Williams, C.M.4
  • 16
    • 78651410455 scopus 로고    scopus 로고
    • A low-Δ9tetrahydrocannabinol cannabis extract induces hyperphagia in rats
    • Oct 21.
    • J.A. Farrimond, B.J. Whalley, C.M. Williams. A low-Δ9tetrahydrocannabinol cannabis extract induces hyperphagia in rats. Behav. Pharmacol. 2010b Oct 21.
    • (2010) Behav. Pharmacol.
    • Farrimond, J.A.1    Whalley, B.J.2    Williams, C.M.3
  • 17
    • 67649856310 scopus 로고    scopus 로고
    • Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice
    • G. Riedel, P. Fadda, S. McKillop-Smith, R.G. Pertwee, B. Platt, L. Robinson. Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice. Br. J. Pharmacol. 2009, 156, 1154.
    • (2009) Br. J. Pharmacol. , vol.156 , pp. 1154
    • Riedel, G.1    Fadda, P.2    McKillop-Smith, S.3    Pertwee, R.G.4    Platt, B.5    Robinson, L.6
  • 18
    • 84865128216 scopus 로고    scopus 로고
    • Cannabinol and cannabidiol exert opposing effects on rat feeding patterns
    • Berl
    • J.A. Farrimond, B.J. Whalley, C.M. Williams. Cannabinol and cannabidiol exert opposing effects on rat feeding patterns. Psychopharmacol. (Berl.) 2012, 223, 117.
    • (2012) Psychopharmacol. , vol.223 , pp. 117
    • Farrimond, J.A.1    Whalley, B.J.2    Williams, C.M.3
  • 19
    • 79551647321 scopus 로고    scopus 로고
    • Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists
    • A.A. Scopinho, F.S. Guimarães, F.M. Corrêa, L.B. Resstel. Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists. Pharmacol. Biochem. Behav. 2011, 98, 268.
    • (2011) Pharmacol. Biochem. Behav. , vol.98 , pp. 268
    • Scopinho, A.A.1    Guimarães, F.S.2    Corrêa, F.M.3    Resstel, L.B.4
  • 20
  • 21
    • 79551662698 scopus 로고    scopus 로고
    • Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation
    • J.A. Farrimond, M.S. Mercier, B.J. Whalley, C.M. Williams. Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation. Phytother. Res. 2011, 25, 170.
    • (2011) Phytother. Res. , vol.25 , pp. 170
    • Farrimond, J.A.1    Mercier, M.S.2    Whalley, B.J.3    Williams, C.M.4
  • 24
    • 84856481281 scopus 로고    scopus 로고
    • The role of the endocannabinoid system in the neuroendocrine regulation of energy balance
    • F.J. Bermudez-Silva, P. Cardinal, D. Cota. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. J. Psychopharmacol. 2012, 26, 114.
    • (2012) J. Psychopharmacol. , vol.26 , pp. 114
    • Bermudez-Silva, F.J.1    Cardinal, P.2    Cota, D.3
  • 27
    • 1642298863 scopus 로고    scopus 로고
    • Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin
    • G. Burdyga, S. Lal, A. Varro, R. Dimaline, D.G. Thompson, G.J. Dockray. Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J. Neurosci. 2004, 24, 2708.
    • (2004) J. Neurosci. , vol.24 , pp. 2708
    • Burdyga, G.1    Lal, S.2    Varro, A.3    Dimaline, R.4    Thompson, D.G.5    Dockray, G.J.6
  • 28
    • 58849117501 scopus 로고    scopus 로고
    • The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure
    • Silver Spring
    • A.N. Verty, A.M. Allen, B.J. Oldfield. The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure. Obesity (Silver Spring) 2009, 17, 254.
    • (2009) Obesity , vol.17 , pp. 254
    • Verty, A.N.1    Allen, A.M.2    Oldfield, B.J.3
  • 32
    • 34249898186 scopus 로고    scopus 로고
    • Rapid glucocorticoid actions in the hypothalamus as a mechanism of homeostatic integration
    • Silver Spring
    • J.G. Tasker. Rapid glucocorticoid actions in the hypothalamus as a mechanism of homeostatic integration. Obesity (Silver Spring) 2006, 14, S259S.
    • (2006) Obesity , vol.14
    • Tasker, J.G.1
  • 34
    • 82155181584 scopus 로고    scopus 로고
    • Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat
    • E. Bojanowska, E. Radziszewska. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat. J. Physiol. Pharmacol. 2011, 62, 395.
    • (2011) J. Physiol. Pharmacol. , vol.62 , pp. 395
    • Bojanowska, E.1    Radziszewska, E.2
  • 35
    • 84862167328 scopus 로고    scopus 로고
    • Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity
    • Lond
    • B. Gatta-Cherifi, I. Matias, M. Vallée, A. Tabarin, G. Marsicano, P.V. Piazza, D. Cota. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity. Int. J. Obes. (Lond.) 2012, 36, 880.
    • (2012) Int. J. Obes. , vol.36 , pp. 880
    • Gatta-Cherifi, B.1    Matias, I.2    Vallée, M.3    Tabarin, A.4    Marsicano, G.5    Piazza, P.V.6    Cota, D.7
  • 36
    • 77956180425 scopus 로고    scopus 로고
    • The tempted brain eats: pleasure and desire circuits in obesity and eating disorders
    • K.C. Berridge, C.Y. Ho, J.M. Richard, A.G. DiFeliceantonio. The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res. 2010, 1350, 43.
    • (2010) Brain Res. , vol.1350 , pp. 43
    • Berridge, K.C.1    Ho, C.Y.2    Richard, J.M.3    DiFeliceantonio, A.G.4
  • 37
    • 84892451413 scopus 로고    scopus 로고
    • Regulation of brain reward by the endocannabinoid system: a critical review of behavioral studies in animals
    • Jun 14. [Epub ahead of print] PubMed PMID: 23829366.
    • S. Vlachou, G. Panagis. Regulation of brain reward by the endocannabinoid system: a critical review of behavioral studies in animals. Curr. Pharm. Des. 2013 Jun 14. [Epub ahead of print] PubMed PMID: 23829366.
    • (2013) Curr. Pharm. Des.
    • Vlachou, S.1    Panagis, G.2
  • 38
    • 34248551106 scopus 로고    scopus 로고
    • The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food
    • T. Melis, S. Succu, F. Sanna, A. Boi, A. Argiolas, M.R. Melis. The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food. Neurosci. Lett. 2007, 419, 231.
    • (2007) Neurosci. Lett. , vol.419 , pp. 231
    • Melis, T.1    Succu, S.2    Sanna, F.3    Boi, A.4    Argiolas, A.5    Melis, M.R.6
  • 42
    • 0037592289 scopus 로고    scopus 로고
    • Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets
    • E.R. Partosoedarso, T.P. Abrahams, R.T. Scullion, J.M. Moerschbaecher, P.J. Hornby. Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets. J. Physiol. 2003, 550, 149.
    • (2003) J. Physiol. , vol.550 , pp. 149
    • Partosoedarso, E.R.1    Abrahams, T.P.2    Scullion, R.T.3    Moerschbaecher, J.M.4    Hornby, P.J.5
  • 44
    • 0037374766 scopus 로고    scopus 로고
    • The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells
    • M. Bensaid, M. Gary-Bobo, A. Esclangon, J.P. Maffrand, G. Le Fur, F. Oury-Donat, P. Soubrié. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol. Pharmacol. 2003, 63, 908.
    • (2003) Mol. Pharmacol. , vol.63 , pp. 908
    • Bensaid, M.1    Gary-Bobo, M.2    Esclangon, A.3    Maffrand, J.P.4    Le Fur, G.5    Oury-Donat, F.6    Soubrié, P.7
  • 48
    • 42449164329 scopus 로고    scopus 로고
    • Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats
    • A.W. Herling, S. Kilp, R. Elvert, G. Haschke, W. Kramer. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats. Endocrinol. 2008, 149, 2557.
    • (2008) Endocrinol. , vol.149 , pp. 2557
    • Herling, A.W.1    Kilp, S.2    Elvert, R.3    Haschke, G.4    Kramer, W.5
  • 53
    • 77958105428 scopus 로고    scopus 로고
    • Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle
    • K.A. Lindborg, M.K. Teachey, S. Jacob, E.J. Henriksen. Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle. Diabetes Obes. Metab. 2010, 12, 722.
    • (2010) Diabetes Obes. Metab. , vol.12 , pp. 722
    • Lindborg, K.A.1    Teachey, M.K.2    Jacob, S.3    Henriksen, E.J.4
  • 54
    • 13244249625 scopus 로고    scopus 로고
    • Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice
    • Lond
    • Y.L. Liu, I.P. Connoley, C.A. Wilson, M.J. Stock. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice. Int. J. Obes. (Lond.) 2005, 29, 183.
    • (2005) Int. J. Obes. , vol.29 , pp. 183
    • Liu, Y.L.1    Connoley, I.P.2    Wilson, C.A.3    Stock, M.J.4
  • 55
    • 77449118145 scopus 로고    scopus 로고
    • Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells
    • C. Lipina, C. Stretton, S. Hastings, J.S. Hundal, K. Mackie, A.J. Irving, H.S. Hundal. Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells. Diabetes 2010, 59, 375.
    • (2010) Diabetes , vol.59 , pp. 375
    • Lipina, C.1    Stretton, C.2    Hastings, S.3    Hundal, J.S.4    Mackie, K.5    Irving, A.J.6    Hundal, H.S.7
  • 59
    • 79551690033 scopus 로고    scopus 로고
    • Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas
    • C. Li, P.M. Jones, S.J. Persaud. Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas. Pharmacol. Ther. 2011, 129, 307.
    • (2011) Pharmacol. Ther. , vol.129 , pp. 307
    • Li, C.1    Jones, P.M.2    Persaud, S.J.3
  • 62
    • 70349515011 scopus 로고    scopus 로고
    • The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets
    • Silver Spring
    • L. Getty-Kaushik, A.M. Richard, J.T. Deeney, S. Krawczyk, O. Shirihai, B.E. Corkey. The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets. Obesity (Silver Spring). 2009, 17, 1856.
    • (2009) Obesity , vol.17 , pp. 1856
    • Getty-Kaushik, L.1    Richard, A.M.2    Deeney, J.T.3    Krawczyk, S.4    Shirihai, O.5    Corkey, B.E.6
  • 64
    • 85153008197 scopus 로고    scopus 로고
    • WHO. Obesity and overweight. Obesity and overweight. Fact Sheet No. 311. Available at:. [1 August 2013].
    • WHO. Obesity and overweight. Obesity and overweight. Fact Sheet No. 311. 2013. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/. [1 August 2013].
    • (2013)
  • 65
    • 84875879626 scopus 로고    scopus 로고
    • The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders
    • C. Silvestri, V. Di Marzo. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab. 2013, 17(4), 475-90.
    • (2013) Cell Metab. , vol.17 , Issue.4 , pp. 475-490
    • Silvestri, C.1    Di Marzo, V.2
  • 68
    • 17144382751 scopus 로고    scopus 로고
    • RIO-Europe Study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
    • L.F. Van Gaal, A.M. Rissanen, A.J. Scheen, O. Ziegler, S. Rössner. RIO-Europe Study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005, 365, 1389.
    • (2005) Lancet , vol.365 , pp. 1389
    • Van Gaal, L.F.1    Rissanen, A.M.2    Scheen, A.J.3    Ziegler, O.4    Rössner, S.5
  • 69
    • 32644441249 scopus 로고    scopus 로고
    • RIO-North America Study Group. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial
    • F.X. Pi-Sunyer, L.J. Aronne, H.M. Heshmati, J. Devin, J. Rosenstock. RIO-North America Study Group. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 2006, 295, 761.
    • (2006) JAMA , vol.295 , pp. 761
    • Pi-Sunyer, F.X.1    Aronne, L.J.2    Heshmati, H.M.3    Devin, J.4    Rosenstock, J.5
  • 70
    • 27844463517 scopus 로고    scopus 로고
    • Rimonabant in obesity-lipids study group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
    • J.P. Després, A. Golay, L. Sjöström, Rimonabant in obesity-lipids study group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med. 2005, 353, 2121.
    • (2005) N. Engl. J. Med. , vol.353 , pp. 2121
    • Després, J.P.1    Golay, A.2    Sjöström, L.3
  • 71
    • 33751001942 scopus 로고    scopus 로고
    • RIO-Diabetes Study Group. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
    • A.J. Scheen, N. Finer, P. Hollander, M.D. Jensen, L.F. Van Gaal. RIO-Diabetes Study Group. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 2006, 368, 1660.
    • (2006) Lancet , vol.368 , pp. 1660
    • Scheen, A.J.1    Finer, N.2    Hollander, P.3    Jensen, M.D.4    Van Gaal, L.F.5
  • 78
    • 84865335261 scopus 로고    scopus 로고
    • Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
    • C. Silvestri, V. Di Marzo. Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders. Expert Opin. Investig. Drugs 2012, 21, 1309.
    • (2012) Expert Opin. Investig. Drugs , vol.21 , pp. 1309
    • Silvestri, C.1    Di Marzo, V.2
  • 79
    • 67049136364 scopus 로고    scopus 로고
    • Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol
    • T. Bisogno, J.J. Burston, R. Rai, M. Allarà, B. Saha, A. Mahadevan, R.K. Razdan, J.L. Wiley, V. Di Marzo. Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol. ChemMedChem 2009, 4, 946.
    • (2009) ChemMedChem , vol.4 , pp. 946
    • Bisogno, T.1    Burston, J.J.2    Rai, R.3    Allarà, M.4    Saha, B.5    Mahadevan, A.6    Razdan, R.K.7    Wiley, J.L.8    Di Marzo, V.9
  • 83
    • 78751700934 scopus 로고    scopus 로고
    • Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors
    • B. Ignatowska-Jankowska, M.M. Jankowski, A.H. Swiergiel. Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors. Neurosci. Lett. 2011, 18, 82.
    • (2011) Neurosci. Lett. , vol.18 , pp. 82
    • Ignatowska-Jankowska, B.1    Jankowski, M.M.2    Swiergiel, A.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.